Article info
PostScript
Letter
Application of the CSF JCV antibody index to early natalizumab-associated progressive multifocal leukoencephalopathy
- Correspondence to Dr Clemens Warnke, Department of Neurology, University Hospital Cologne, Kerpener Strasse 62, Cologne 50937, Germany; clemens.warnke{at}uk-koeln.de
Citation
Application of the CSF JCV antibody index to early natalizumab-associated progressive multifocal leukoencephalopathy
Publication history
- Received November 16, 2016
- Revised April 4, 2017
- Accepted April 9, 2017
- First published May 10, 2017.
Online issue publication
November 28, 2017
Article Versions
- Previous version (10 May 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.